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Abstract
To determine the normal function of the Coxsackievirus and Adenovirus Receptor (CAR), a protein found in tight junctions
and other intercellular complexes, we constructed a mouse line in which the CAR gene could be disrupted at any chosen
time point in a broad spectrum of cell types and tissues. All knockouts examined displayed a dilated intestinal tract and
atrophy of the exocrine pancreas with appearance of tubular complexes characteristic of acinar-to-ductal metaplasia. The
mice also exhibited a complete atrio-ventricular block and abnormal thymopoiesis. These results demonstrate that CAR
exerts important functions in the physiology of several organs in vivo.
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Introduction
Coxsackievirus and adenovirus receptor (CXADR or CAR) is a
cell adhesion molecule that acts as a cellular receptor for both
coxsackie B and many species of adenovirus, and has attracted
attention for its importance in virus-related disease and for the
development of adenovirus as a vector for gene therapy [1].
CAR belongs to a subfamily within the immunoglobulin
superfamily. It contains a membrane-distal V-type and a
membrane-proximal C2-type immunoglobulin domain, a single
transmembrane region, and a cytoplasmic tail. Members of this
subfamily including junctional adhesion molecules (JAMs), endo-
thelial-cell-selective adhesion molecule (ESAM) and CAR are
mainly expressed on the surface of endothelial and epithelial cells
where they regulate the migration of immune cells across
endothelial and/or epithelial barriers and aid in the establishment
of cell polarity and barrier function of endothelial and/or
epithelial tissues [2,3].
Expression of the Car gene is developmentally regulated. Mouse
embryos express the protein abundantly, whereas expression in the
adult mouse is more restricted and confined mainly to the tight
junctions of epithelial cells where CAR contributes to barrier
function [1,4,5]. The CAR protein is also localized to neuromus-
cular junctions, intercalated discs in the heart and to the acrosome
region of germ cells in the testis [6,7].
A functional role of CAR in cardiac development has recently
been demonstrated. Targeted disruption of CAR is embryonically
lethal due to heart failure early in embryogenesis [8,9,10].
Importantly, embryos with cardiac-specific deletion of CAR
induced after embryonic day 11 (E11) are viable but develop an
atrioventricular heart block (AV-block) that is maintained to
adulthood without any increase in mortality [10,11]. A complete
AV-block also develops in adult mice with a cardiac-specific
depletion of CAR. In these mice an altered localization of
connexin 45, ß-catenin and zonula occludens-1 (ZO-1) preceded
development of cardiac dysfunction [11]. Moreover, a defective
communication through tight- and gap junctions in cardiomyo-
cytes has been suggested [12]. In contrast, cardiac-specific
overexpression of CAR causes disorganization and degeneration
of cardiomyocytes, disrupted adherens junctions, cardiomyopathy
and ultimately animal death [13]. Overexpression of CAR driven
by a skeletal muscle-specific promoter results in a severe and lethal
myopathic phenotype [14]. These results indicate that a tight
regulation of CAR protein levels is required for proper muscle
tissue function. Ubiquitous over-expression of the extracellular and
transmembrane domains of CAR does not result in any obvious
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animal phenotype in vivo, showing that the complete protein
including the intracellular tail region is required for the
downstream signalling and the physiological effects of CAR [14].
The signalling pathways that modulate CAR-mediated func-
tions are not well understood. CAR protein levels are dynamically
regulated by inflammatory responses and signals that control
proliferation and differentiation including the Raf/MEK/ERK,
FSH and TGF-ß mediated signalling pathways [15,16,17,18,
19,20,21,22]. CAR has also been associated with an activation of
both b-catenin- MAPK and PI3K signaling pathways [13,23,24].
Several PDZ-domain containing proteins including ligand-of-
numb protein-X (LNX), ligand-of-numb protein-X2 (LNX2),
zonula occludens-1 (ZO-1), membrane-associated guanylate
kinase 1b (MAGI-1b), protein interacting with protein C kinase
(PICK1), postsynaptic density95 (PSD-95) and multi-PDZ domain
protein-1 (MUPP1) interact with the intracellular tail of CAR
suggesting that CAR is present in larger protein complexes
[5,25,26,27,28]. In addition, CAR can form homophilic interac-
tions with CAR molecules on neighbouring cells as well as with
JAM-C and JAML suggesting that cross talk occurs between
members of this immunoglobulin subfamily [7,29,30]. CAR is also
found in the same protein complex as connexin 45, a gap junction
protein, and with components of the cytoskeleton [11,31,32].
Since deletion of the Car gene produces an embryonic lethal
phenotype it has not been possible to analyse the integrated
function of CAR in a broader range of tissues in the adult
organism. We have therefore developed a mouse strain with a
conditional ablation of Car in order to carry out temporally
controlled global inactivation of the Car gene. Here we
demonstrate a role for CAR in the physiology of the heart,
pancreas, intestine and thymus in adult mice.
Methods
Ethics Statement
All animal experimentation was conducted in accordance with
accepted standards of humane animal care, and was approved by
Stockholm North Animal Ethical Board (N179/08).
Generation of conditional Car knockout mice
Mice with a loxP-flanked Car allele (F/F mice) were generated at
the MCI/ICS (Mouse Clinical Institute - Institut Clinique de la
Souris-, Illkirch, France; http://www-mci.u-strasbg.fr). Three
fragments corresponding to a 4.3 kb 59 homology arm, a 0.4 kb
fragment harbouring exon-2 and two flanking loxP sites, and a
2.8 kb 39 homology arm were amplified by PCR from 129S2/
SvPas ES cells and subcloned in an MCI proprietary vector
harbouring a neomycin selection cassette flanked by flippase
recognition target sites. The linearized construct was electropo-
rated into 129S2/SvPas mouse embryonic stem (ES) cells. After
selection, targeted clones were identified by PCR using external
primers and further confirmed by Southern blot with 59 and 39
external probes. The neomycin cassette was removed and two
positive ES clones were injected into C57Bl/6J blastocysts, and
male chimaeras generating germline transmission were identified
and used for further breeding.
F/F mice were then crossed with the transgenic mouse line
B6.Cg-Tg (CreEsr1)5AmC/J (purchased from The Jackson
Laboratory) expressing a tamoxifen-inducible Cre-ERTM fusion
protein under the control of a chicken ß actin/cytomegalovirus
(CMV) promoter [33]. Additional breeding created the mouse line
F/F;Cre that was backcrossed three times onto C57Bl/6J and then
used for experiments.
Cre-mediated deletion of exon 2 results in a frame shift and
premature termination within the CAR leader sequence, creating
a null allele. The first exon comprising 15 of the 19 amino acids
that constitute the signal peptide remain intact. Following the
frameshift, the transcript from the null allele encodes 9 amino
acids unrelated to CAR (HFVFWRQNL) followed by a stop
codon. No abnormal transcripts were observed in tissues from
cKO animals when analyzed by RT-PCR using primers for the 59
and 39 ends of the transcript (data not shown), and Western blot
analyses using all our in house CAR antibodies (IG1, RP1284 and
RP291) did not reveal any shortened CAR variants.
Genotyping
Genotyping of mice was performed by PCR amplification of
genomic DNA isolated from the tail. Primer pairs (GAGACTG-
GATTATGAGTTCCAGGCTTTAG) and (GCTATTCATGG-
GAGCAAAGTGATACAGG) were used to amplify an area
encompassing one of the loxP sites. The size of the DNA fragments
was 211 bp for the wildtype (wt) allele and 261 bp for the floxed
allele. Cre-specific primers (GCGGTCTGGCAGTAAAAAC-
TATC) and (GTGAAACAGCATTGCTGTCACTT) amplified
a 100 bp fragment in animals harbouring the Cre transgene.
Following tamoxifen treatment, the Car null allele was identified
with primers (GAGACTGGATTATGAGTTCCAGGCTTTAG)
recognizing Car on chr 16 position 74433415–74433443
(NW001030584) and (CCTGCTCCAGATTCCCACAATTCC)
recognizing Car on chr 16 position 74434106–74434129
(NW001030584.1) that amplified a region encompassing both
loxP sites and the second exon. The size of the amplified DNA
fragment was reduced from 874 bp (floxed allele) to 409 bp (Car
null allele). The size of the corresponding wt allele was 741 bp.
Nomenclature
The following nomenclature is used for mice throughout the
paper. +/+ animals are wt C57Bl/6J mice, cKO are tamoxifen-
treated animals with the genotype F/F;Cre, Ctrl are control
animals with genotype +/+ or F/F as indicated in the text,
+/+;Cre animals express the Cre recombinase but do not contain
any loxP sites.
CAR and Car is used throughout the paper and refers to the
protein and the CXADR gene, respectively.
Tamoxifen treatments
Tamoxifen (Sigma, T5648) was dissolved in corn oil (Sigma,
C8267) to a final concentration of 10–20 mg/ml by vigorous
shaking at 55uC for a couple of hours. Dissolved tamoxifen was
prepared fresh and used within a week. Adult animals (minimal
age 3 weeks) were injected intraperitoneally with tamoxifen
(0.1 mg/g body weight) once a day for five consecutive days
(day 1–5). If not stated otherwise animals were given a booster
dose one week later (day 12). Mice were generally sacrificed on day
19 (standard protocol). In some cases additional booster doses were
given, and the day for sacrifice was prolonged (up to 18 months) as
indicated in the text.
Tissue preparations and analyses
For histology, the gastrointestinal tract was removed from the
abdominal part of the oesophagus to the rectum. The mesentery
containing the pancreas as well as regional lymph nodes was
bluntly removed from the intestine apart from the most proximal
part. The intestine was immersed in phosphate buffered 4%
formalin (Solveco AB, cat # 1198), fixed for 24 hrs and then kept
in 70% ethanol until analysis. The proximal intestine with
Phenotypes in CAR-Depleted Adult Mice
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attached pancreas and mesentery was laid flat on a piece of paper
and fixed for a total of 24 hours, dehydrated and embedded in
paraffin according to standard procedures. Paraffin sections were
dewaxed and stained with haematoxylin/eosin.
For Transmission Electron Microscopy (TEM) tissue was
dissected and small pieces were fixed in 2% glutaraldehyde
+0.5% paraformaldehyde in 0.1 M sodiumcacodylate buffer
containing 0.1 M sucrose and 3 mM CaCl2, pH 7.4 at room
temperature for 30 min followed by 24 hours at 4uC. Specimens
were rinsed in 0.15 M sodiumcacodylate buffer containing 3 mM
CaCl2, pH 7.4 postfixed in 2% osmium tetroxide in 0.07 M
sodiumcacodylate buffer containing 1.5 mM CaCl2, pH 7.4 at
4uC for 2 hrs, dehydrated in ethanol followed by acetone and
embedded in LX-112 (Ladd, Burlington, Vermont, USA).
Semithin sections were cut and stained with Toluidinblue O
(Merck, Darmstadt, Germany) and used for light microscopic
analysis. Ultrathin section (approximately 40–50 nm) were cut and
contrasted with uranyl acetate (Merck, Darmstadt, Germany)
followed by lead citrate (Merck, Darmstadt, Germany) and
examined in a Leo 906 transmission electron microscope at
80 kV (Park et al, 2007). Digital images were taken by using a
Morada digital camera (Soft Imaging System, GmbH, Mu¨nster,
Germany).
For analyses of thymocytes and T-cell sub populations the
thymus and spleen were passaged through a steel net. Cells were
washed and resuspended in cold, complete RPMI medium (Gibco,
61870) supplemented with 50 IU/ml penicillin, 50 mg/ml
streptomycin, 2 mM L-glutamine and 10% heat-inactivated fetal
calf serum, all obtained from Gibco-BRL (Paisley, Scotland).
Splenocytes were treated with red blood cells lysing buffer (Sigma,
R7757) for a 5 minutes at room temperature to lyse the red blood
cells. Leukocytes were washed twice and resuspended in complete
RPMI medium supplemented with 50 IU/ml penicillin, 50 mg/
ml streptomycin, 2 mM glutamine and 10% fetal calf serum.
Thymocytes and purified leukocytes from spleen and blood were
stained with anti-CD4-FITC and anti-CD8-PE antibodies in ice-
cold complete RPMI medium for 1 h on ice. After washing,
10,000 cells were analyzed by flow cytometry in a FACSscan
(Becton Dickinson and Co., Franklin Lakes, NJ). Cells were gated
to exclude debris and clumps.
Indirect double immunofluorescence, protein extraction
and Western blot analysis
These methods have been described previously [7,22,25].
Modifications from the described methods were that mounting
media containing 49,6-diamidino-2-phenylindole (DAPI) (Vectra-
Sheild H1200 ) was used in the double immunofluorescence
analyses and that preparation of protein extracts from certain
tissues required both homogenization and sonication in ice-cold
urea lysis buffer (8 M urea, 0.2% SDS, 0.8% Triton-X100, 3% 2-
mercaptoethanol and complete protease inhibitors) [4]. Protein
concentrations in cell extracts were quantified by conventional
Bradford analysis or by using a commercially available kit (Bio-
Rad Laboratories, 500-0006). The same concentration of SDS and
Triton X-100 used in the lysis buffer was also used in the blank
and standards. Calnexin was included as a loading control in the
Western blot analyses.
Antibodies
Rabbit, polyclonal anti-CAR antibodies (IG1, RP1284 and RP
291) and the antibody towards Calnexin have been described
previously [4,34]. The antibody towards IG1 recognizes the first
immunoglobulin loop in the CAR protein. RP291 recognizes the
C-terminal region of CAR-2 (VMIPAQSKDGSIV in the human
protein). RP1284 recognizes amino acids 315–331 present in the
cytoplasmic tail of mouse CAR common to both major isoforms
(KTQYNQVPSEDFERAPQ). All CAR antibodies recognize
both mouse and human CAR proteins. The rat monoclonal
anti-occludin antibody (MOC37) was a kind gift from Dr. M.
Furuse, Kobe University, Japan. The rat monoclonal anti-ZO-1
antibody was purchased from Chemicon (MAB1520). For flow
cytometry anti-CD4-FITC and anti-CD8-PE monoclonal anti-
bodies (11-0041-81 and 12-0081-81, EBioSciences San Diego,
CA) were used. Secondary antibodies were donkey anti-rabbit
Alexa Fluor 488 (A21206, Molecular Probes Inc, Eugene, OR)
donkey anti-rat Alexa Fluor 594 (A21209 Molecular Probes Inc,
Eugene, OR) and HRP labelled anti-rabbit Ig (NA934V, GE
health care, UK).
Urine analysis
Combur-Test (Roche) strips were used on fresh voided urine for
semi quantitative assessment of pH, leukocytes, nitrate, protein,
glucose, ketones, urobilinogen, bilirubin, hemoglobin, and red
blood cells.
Blood analysis
Blood samples were collected from the tail into serum separator
microtubes containing no anticoagulants, then centrifuged and
frozen until analysis. The concentrations of different biochemical
parameters were determined in individual serum samples using an
autoanalyzer.
Shirpa test
The Shirpa primary screen was used to assess the behavioural
and functional profile on mice 2–6 months of age [35]. A clear
Perspex cylinder with a 14 cm diameter and 18 cm height placed
on tripod of 10 cm height was used for the evaluation of
undisturbed behaviour for 5 min. Subsequently, the mouse was
transferred to an arena (54632 cm) for observation of motor
behaviour. Thereafter, a sequence of manipulations using tail
suspension and supine restraint was performed to evaluate
parameters such as grip strength, limb tone, and reflexes. The
procedure was ended by the measurement of body weight. The
equipment was cleaned with 70% ethanol between animals.
Scoring was performed as proposed by Hatcher et al [36] with
some modifications as suggested by the standard operating
procedures in Eumorphia EMPReSS (http://empress.har.mrc.
ac.uk/). Respiration, heart rate, salivation, fear, irritability, and
body temperature were not assessed.
Electrocardiography (ECG)
28–37 week old mice were anesthetised with isoflurane (Forene,
Baxter, USA). Needle electrodes were inserted under the skin in
the thoracic region rostral and caudal to the heart. ECG signals
were captured using BioAmp (AD Instruments, Australia) and
Powerlab (ADInstruments Ltd, Oxfordshire, UK) systems, and
analysed using Chart v4.2 (ADInstruments). For each animal at
least 30 seconds of data was recorded and analysed for rhythm.
Representative regions with minimal movement artefacts were
used to analyse atrial and ventricular rates and PQ intervals.
Assessment of intestinal permeability
Intestinal permeability was assessed as described in [37] using
fluorescein-isothiocyanate-conjugated dextran-4000 (FITC-dex-
tran) as a permeability probe. FITC-dextran (Sigma Chemical
Co.) was prepared in a concentration of 20 mg/ml in PBS.
Phenotypes in CAR-Depleted Adult Mice
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30 mg/100 g body weight was administered by gavage 4 h prior
to sacrifice.
Statistical methods
Data are presented as mean6 SD or mean6 SEM, as stated in
the text. For data analysis, a two-tailed Student’s t test was used
and p,0.05 was considered significant. The number of experi-
ments is indicated in the text.
Results
Generation of conditional Car knockout mice
We constructed a floxed Car allele that can be disrupted at any
chosen time point by tamoxifen-regulated Cre-mediated recom-
bination in vivo (Fig. 1A). Genotypes were determined by PCR
amplification of genomic DNA isolated from the tail (Fig. 1B and
data not shown).
RT-PCR, Western blot and indirect immunofluorescence
analyses did not reveal any difference between wt (+/+) and
floxed (F/F) mice regarding CAR mRNA expression, total amount
of CAR protein or subcellular localization of CAR in any organ
tested (Figs. 1C and D, and data not shown). We therefore
conclude that insertion of loxP sites in the non-coding parts
surrounding the 2nd exon does not affect expression from the Car
gene. Similarly, introduction of the Cre expression cassette did not
affect CAR expression in the absence of tamoxifen, since Western
blot and indirect immunofluorescence analyses showed that CAR
protein levels and subcellular localization were indistinguishable
between wt (+/+) and mice harbouring the Cre transgene (Figs. 1C
and data not shown). In addition, indirect immunofluorescence
using a Cre-specific antibody confirmed that no nuclear Cre
protein was found in organs isolated from F/F;Cre animals, and
no DNA excision originating from recombination between the two
loxP sites was detected in PCR analysis (data not shown). We
conclude that the Cre protein does not cause any detectable
recombination in F/F;Cre mice in the absence of tamoxifen and
that neither the F/F nor the F/F;Cre mice in the absence of
tamoxifen differ from wildtype mice with regard to CAR gene
expression.
Tamoxifen induce an efficient Cre-mediated inactivation
of the Car gene
To determine whether administration of tamoxifen could
induce recombination between the loxP sites, littermates of F/
F;Cre (cKO) and F/F controls (Ctrl) were given tamoxifen by
intraperitoneal injections. Mice were sacrificed between one week
and 18 months after the last tamoxifen administration and
analyzed by PCR and Western blotting.
PCR performed on DNA isolated from the tail demonstrated an
efficient excision of the second exon specifically in the cKOs
(Fig. 2A). The same result was seen when PCR was performed on
DNA isolated from other organs including kidney, heart and
spleen (data not shown). One notable exception was the liver, in
which the recombination was much less efficient compared to the
other organs tested (data not shown). This observation was in
accordance with a previous report, demonstrating reduced
Figure 1. Construction of a conditional Car knockout mouse. (A) Schematic presentation of the targeting strategy. Tamoxifen is required to
produce a Car null allele (cKO). (B) PCR analysis of genomic DNA isolated from the mouse tail. The genotype of wt (+/+), heterozygote (F/+) and
homozygote (F/F) mice is indicated. The 261 bp and 211 bp PCR products corresponds to floxed and wt alleles respectively. (C) Western blotting of
protein extracts prepared from pancreas shows that insertion of loxP sites and the Cre transgene do not affect CAR protein levels in the absence of
tamoxifen. Genotypes and molecular weight markers are indicated. The CAR-specific antibody RP291 was used to detect CAR. The same result was
obtained with the antibody RP1284 (data not shown). Calnexin was used as a loading control. The experiment was performed .3 times. (D) Indirect
immunofluorescence on sections from large intestine was used to demonstrate that insertion of loxP sites did not affect the subcellular localization of
the CAR protein in the absence of tamoxifen. Genotypes are indicated. The CAR-specific antibody RP291 was used to detect CAR (green). The same
result was obtained when the IG1 antibody was used to detect CAR (data not shown). DAPI was used to visualize nuclei (blue). Magnification was
406. (i) and (ii) are enlargements of the boxed areas in the +/+ and F/F image, respectively. The experiment was performed 3 times.
doi:10.1371/journal.pone.0020203.g001
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efficiency of the CMV-Cre-ERTM system in the liver [33]. The
low recombination efficiency in the liver might reflect a
metabolization and subsequent inactivation of the drug.
Protein extracts were prepared from different organs and the
expression of CAR protein was analyzed by Western blotting.
Inactivation of the Car gene in cKO animals was associated with a
significant decrease in CAR protein levels in most organs analyzed
(Fig. 2B). The amount of CAR protein in the liver was still
relatively high in the cKO, which correlated well with the results
of the PCR analysis. The low CAR protein levels were maintained
for at least 18 months after the last tamoxifen administration
(length of experiment). These results show that the Car gene can be
irreversibly inactivated in a broad range of tissues in adult F/F;Cre
mice in the presence of tamoxifen.
The CAR protein levels in tamoxifen-treated F/F and +/+;Cre
control animals were indistinguishable from wt demonstrating that
neither tamoxifen treatment itself nor the presence of the Cre
protein alone can disrupt expression from the Car gene (Fig. 2C).
Metabolism, fertility, behaviour and locomotion activity
in cKO mice
To evaluate metabolism, fertility, behaviour and locomotion
activity, tamoxifen was injected into littermate F/F;Cre (cKO) and
F/F control (Ctrl) animals. Animals (cKO, n= 20; controls, n = 21)
were weighed weekly for six months, however no difference in
weight gain between the two groups was observed (Fig. 3). The
cKO animals were fertile and appeared healthy with no increase
in mortality compared to controls. The cKO animals showed a
tendency for early onset of grey fur, but statistical analysis could
not confirm the significance of this finding.
Faeces and fresh voided urine samples were obtained from
tamoxifen-injected cKO mice (n = 20) and littermate controls
(n = 25) over a period of 6 months and colour, pH, leukocytes,
nitrate, protein, glucose, ketones, urobilinogen, bilirubin, hemo-
globin and red blood cells were analyzed. No differences between
the two groups were found (data not shown). Faeces appeared
normal in consistency and pellet-size. No sign of constipation,
diarrhoea or bleeding was observed.
Serum samples from cKO (n=17) and littermate controls
(n = 18) were collected and the concentration of different
biochemical parameters was determined. No significant difference
was found between the two groups. The concentration of the
serum parameters in cKO vs. controls was as follow. Total Protein
(g/L) 52.1264.34 vs. 51.3962.59; Albumin (g/L) 33.7161.65 vs.
33.0661.06; Amylase (mkat/L) 35.9567.48 vs. 38.3766.79; Bile
Acid (mmol/L) 7.0665.37 vs. 9.3466.51; Cholesterol (mmol/L)
1.6860.38 vs. 1.8460.38; Triglyceride (mmol/L) 0.8760.23 vs.
0.7560.21; ASAT (mkat/L) 1.1260.43 vs. 0.960.25; Creatinin
(mmol/L) 30.94617.36 vs. 26.53612.4.
Figure 2. Inactivation of the Car gene following tamoxifen administration. (A) Genomic tail DNA was isolated from tamoxifen-treated
animals with genotypes F/F (ctrl, lane 1) and F/F;Cre (cKO, lane 2). PCR amplification demonstrated that an efficient excision of exon 2 was specifically
obtained in the cKO animals. (B) Western blot analysis of organ extracts from tamoxifen-treated F/F control (Ctrl) and F/F;Cre (cKO) animals. The CAR-
specific antibody RP291 was used to detect CAR. The same result was obtained with RP1284 (data not shown). Calnexin was used as a loading
control. The experiment was performed at least three times. (C) Western blotting of protein-extracts prepared from lungs of tamoxifen-treated mice.
No loss of CAR protein is found in animals with genotypes +/+;Cre (lane 1) or F/F (lane 3) as compared to wt controls (lane 2) in the presence of
tamoxifen. The CAR-specific antibody RP291 was used to detect CAR. The same result was obtained with RP1284 (data not shown). Calnexin was used
as a loading control. The experiment was performed at least three times.
doi:10.1371/journal.pone.0020203.g002
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An observational assessment of locomotor function and sensory
system behavior using the SHIRPA primary screen of standard-
ized protocols was done on tamoxifen-injected F/F;Cre (cKO,
n=13) and F/F littermate controls (Ctrl, n = 10). Only one of the
35 tests showed a significant difference between cKO and control
mice, the transfer arousal test, which measures the immediate
reaction to a new environment. The cKO mice showed a lower
tendency to freeze and instead moved immediately. In this test
46% of the cKO mice froze momentarily before starting to explore
and 54% immediately explored the area, as compared to the
control mice of which 80% froze momentarily and only 10%
showed immediate movement (data not shown). Extended freezing
would imply anxiety or fear. The behavior of the control mice, to
freeze for not more than 5 seconds initially, is however considered
normal. If the lack of freezing of the cKO mice would be caused
by hyperactivity, that behavior was not recorded in the viewing jar
or in locomotor activity and the importance of this finding is
therefore unclear.
Dilated intestines and atrophy of the exocrine pancreas
in cKO mice
Littermates of F/F;Cre (cKO, n.30) and F/F controls (Ctrl,
n.30) were treated with tamoxifen. Necropsy one week after the
last tamoxifen administration revealed major macroscopic changes
in the intestinal system and pancreas (Figs. 4A and B). The
intestine of all cKO animals analyzed was dilated (Fig. 4A). The
overall length of the gastrointestinal tract was not affected (data
not shown). In addition, the pancreas was found to be dramatically
smaller in all cKO mice compared to the controls (Fig. 4B).
Interestingly, cKO mice analyzed up to 18 months after the last
tamoxifen injection maintained the dilated intestines and the
pancreatic atrophy indicating that these effects were irreversible.
No polyps or tumors were found.
Tissues were collected from F/F;Cre (cKO, n= 12) and F/F
controls (Ctrl, n = 12) animals one week up to 18 months after the
last administration of tamoxifen, and analyzed by haematoxylin
and eosin staining. Major histological changes were found in the
pancreas. While the exocrine pancreas in control mice had large,
polarized acinar cells and associated ducts surrounding richly
vascularised Islets of Langerhans, the cKO mice demonstrated a
striking atrophy of exocrine tissue (Fig. 4C). Pancreas of cKO mice
consisted mainly of adipose tissue in which apparently normal
Islets of Langerhans were interspersed. There was an almost
complete lack of acinar cells and only small parts of apparently
normal exocrine pancreas could be found. Duct-like tubular
complexes replaced the acinar cells, and the pancreas therefore
displayed a metaplastic phenotype. The atrophy and metaplastic
phenotype was already present three weeks after the initiation of
tamoxifen treatments and was then maintained for more than 18
months indicating that the effect was irreversible. No sign of
fibrosis was observed. No obstruction or damage was found in the
pancreatic ducts or in the associated ducts in the liver and
gallbladder in cKO animals (data not shown).
Neither the dilated intestines nor the pancreatic atrophy were
seen in similarly treated +/+;Cre control mice demonstrating that
the effects were not caused by expression of the Cre protein alone
(data not shown).
An increase in inflammatory cells was observed in the pancreas
of both cKO and controls the first weeks after tamoxifen
administration. This effect was however not maintained and no
sign of pancreatitis were observed in older animals (data not
shown).
No other macroscopic or histological changes were found in the
cKO and all other organs including intestines, heart and thymus
appeared normal. No hemorrhage or edema was found in cKO
animals, and both blood- and lymphatic vessels appeared normal
based on histology and immunofluorescence staining using
endothelial cell markers (data not shown).
Atrioventricular block in cKO mice
ECG was performed 24 weeks (cKO, n= 10; littermate controls,
n = 5) after the last tamoxifen administration. In each animal, at
least 30 seconds of ECG recording was examined. All control mice
exhibited sinus rhythm, without ectopic beats, and with a mean
heart rate of 549625 min21 (mean 6 SD, n= 5, range = 478–
589), and a mean PQ interval (measured from the start of the P
wave to the beginning of the Q wave) of 3865 (mean6 SD, n= 5,
range 32–49 ms) milliseconds. All examined cKO mice showed a
complete atrioventricular (AV) block with temporal dissociation
between atrial depolarisation (P waves) and ventricular depolar-
isation (QRS complexes). Figure 5A shows representative tracings
from a control mouse (top panel) and a cKO mouse (bottom
panel). The cKO mice showed an average P-wave frequency of
4796133 min21 (mean 6 SD, n= 10, range = 248–644), and an
average R-wave frequency of 580647 min21 (mean6SD, n= 10,
range = 527–656). The P-wave frequency was significantly slower
than the R-wave frequency (P,0.05; Student’s t-test). The
ventricular frequency in cKO mice was slightly faster than that
of their control counterparts, however this effect was not
statistically significant (p = 0.20, unpaired Student’s t-test). No
major difference in the duration of the QRS complexes was
observed between the control and the cKO groups.
CAR is expressed in intercalated discs between myocytes [6].
To analyze the junctions between myocytes at the ultrastructural
level, transmission electron microscopy was performed on heart
tissue from tamoxifen-treated F/F;Cre (cKO, n= 3) and F/F
control mice (Ctrl, n = 3). The intercalated discs of the cardiac
muscle in control animals displayed a well-defined and character-
istic step-like morphology i.e. a tight connection between the
myofilaments and abundance of dense material at the intersection
(Fig. 5B). In contrast, the intercalated discs of cardiac muscle in
Figure 3. Body weight of cKO and littermate controls after
tamoxifen administration. The body weights of F/F;Cre (cKO, n = 20)
and F/F littermate control (Ctrl, n = 21) animals were measured weakly
following tamoxifen administration given at 4 weeks of age. No
difference between the two groups was found. Data are presented as
mean 6 SEM.
doi:10.1371/journal.pone.0020203.g003
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Figure 4. Enlarged intestines and atrophy of exocrine pancreas in cKO mice. (A, B) Necropsy of tamoxifen-treated F/F;Cre (cKO) and F/F
controls (Ctrl) revealed enlarged intestines (A) and a dramatic reduction in the size of pancreas (B) in cKO animals. Analysis was repeated .30 times.
(C). Histology of pancreata tissue harvested two weeks after the last tamoxifen administration from F/F control (Ctrl) and F/F;Cre (cKO) animals. (i, ii)
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cKO animals showed a heterogeneous morphology. Although
some areas showed normal morphology, most discs were severely
changed. The most striking observation was a disconnection
between myofilaments and the presence of big vacuoles-containing
parts of membranes. Furthermore the outline of the junction was
also changed i.e. in some areas the distance between zonula
adherens was wider and contained a clot like contents (Fig. 5B).
ECG recording and transmission electron microscopy per-
formed on similarly treated +/+;Cre control mice were indistin-
guishable from wt mice demonstrating that the effects seen in cKO
animals was not caused by expression of the Cre protein alone
(data not shown).
From these experiments we conclude that inactivation of the
CAR gene in adult mice causes irreversible AV-block and
structural changes in adhesion between myocytes confirming the
importance of CAR for normal heart function.
The total number of thymocytes is increased in cKO mice
To investigate possible effects of CAR on thymocytes and
leukocytes, littermates of F/F;Cre (cKO, n= 10) and F/F controls
(Ctrl, n = 10) were treated with tamoxifen. When the thymus and
spleen were removed 2–3 days after the last tamoxifen
administration, thymus was found to be notably larger in cKO
than in control animals (data not shown). Thymocytes and spleen
leukocytes were isolated, counted, and analysed by flow cytometry.
The results demonstrated an increase in the total number of
thymocytes in cKO compared to control mice (P,0.005) (Fig. 6A).
This effect was not seen in +/+;Cre control mice demonstrating
that Cre protein alone could not affect the number of thymocytes
(9865.7% of controls). The percentage of cells in the four
thymocyte populations was unchanged, indicating that all
populations were similarly affected (Fig. 6B). The percentage of
different thymocyte populations in cKO vs. controls was as
Figure 5. Atrioventricular heart block and ultrastructural changes in hearts of cKO mice. (A) Representative ECG recordings of tamoxifen-
treated F/F control (Ctrl, upper panel) and F/F;Cre (cKO, lower panel) animals. A complete AV block was demonstrated in the cKO animals while
control mice showed normal sinus rhythm. Arrows mark the individual P waves. Note the absence of a constant coupling interval between the P
waves and the QRS complexes in cKO mice. (B) Transmission electron microscopy of cardiac muscle from tamoxifen-treated F/F control (Ctrl) and F/
F;Cre (cKO) animals. A disconnection between myofilaments and big vacuoles containing parts of membranes (arrows) and wider zonula adherens
containing a clot like contents (arrow heads) was observed in cKO animals. The experiment was performed on three different animals from each
group. Scale bar = 1 mm.
doi:10.1371/journal.pone.0020203.g005
Control animals displayed an organized structure of exocrine pancreas (Exo) with interspersed Islets of Langerhans (L). Acinar cells were polarized
with more basophilic staining (blue) corresponding to endoplasmic reticulum and accumulation of secretory granules at the apical side. (ii) is a
magnification of the boxed area indicated in (i). (iii–v) Pancreas of cKO mice displayed atrophy of exocrine pancreas, enrichment of adipose tissue and
apparently normal Islets of Langerhans (L). Only small parts of normal exocrine pancreas could be found (Exo). The acinar cells were replaced by duct-
like tubular complexes (T). (v) is a magnification of the boxed area indicated in (iv). Scale bar = 100 mm.
doi:10.1371/journal.pone.0020203.g004
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follows. CD8+ single positive: 6.0861.8 in cKO mice vs. 5.1561.8
in control mice, CD4+ single positive: 9.6361.8 vs. 9.7062.2,
CD4+/CD8+ double positive (DP): 73.1366 vs. 74.8565.4,
CD42/CD82 double negative (DN): 10.4263.7 vs. 9.3361.5.
The increased number of thymocytes in cKO mice was not caused
by an increase in cell proliferation since flow cytometric analysis
did not reveal changes in the percentage of cycling thymocytes in
cKO mice as compared to controls (4.560.4 vs. 4.260.7). In
addition, no significant difference was found in the percentage of
cycling cells among the four different thymocyte populations (data
not shown). The sensitivity of the thymocytes to glucocorticoid-
induced apoptosis was similar in cKO and control mice (data not
shown). Analysis of spleen leukocytes did not reveal a significant
change in the number of T cells (data not shown) or percentage of
CD4+ and CD8+ T cells (Fig. 6B). The percentages of different T
cell populations in cKO vs. controls were as follows. CD4+:
1864.1 vs. 1662.2 and CD8+: 9.564 vs. 7.162.9. There was also
no significant change in the percentage of B cells (47.266.1 vs.
46.863.7).
The intestinal barrier is not affected in cKO mice
The CAR protein is found in the tight junctions of most
epithelial cells in vivo and in vitro. A decrease in the amount of CAR
protein lowers transepithelial resistance and promotes diffusion of
fluorescence markers across epithelial cell layers in vitro [4,26]. To
analyze if inactivation of the Car gene affects epithelial integrity
also in vivo, the intestinal epithelium of tamoxifen-treated F/F;Cre
(cKO, n= 11) and F/F control mice (Ctrl, n = 11) were challenged
with fluorescent tracers administered by gavage. 4 hrs later, blood
samples were taken and analyzed for the presence of fluorescent
tracer. No statistically significant difference between cKO and
control mice was observed indicating a maintained integrity of the
intestinal epithelium (Fig. 7A). Similar results were obtained in
animals devoid of CAR for up to 18 months (length of
experiment). In addition, the cKO mice did not show signs of
dehydration or oedema indicating that the skin barrier as well as
the vascular system was intact.
Haematoxylin and eosin staining of the intestine did not reveal
any differences between tamoxifen-treated control and cKO
animals, and villi, crypts, Peyers patches, submucosa, muscle
and epithelial layers in the cKO mice were all normal (Fig. 7B).
To analyze the tight junction protein complex at the molecular
level, indirect immunofluorescence analysis was performed on
intestinal epithelium using specific antibodies towards CAR and
the junctional marker Occludin (Fig. 7C). Despite an almost
complete lack of CAR in the epithelium of cKO mice, no
difference was found between tamoxifen-treated cKO and control
animals in Occludin expression. The same result was obtained
when ZO-1, another tight junction associated protein, was
analyzed (data not shown). These results indicate that the
molecular composition of the tight junction complexes was
unaffected in cKO mice.
Finally, we used transmission electron microscopy to analyze
junctional complexes in epithelial tissue from the upper part of the
intestine in tamoxifen-treated F/F;Cre (cKO, n=3) and F/F
control mice (Ctrl, n = 3). Although minor changes were
occasionally found in cKO mice, the architecture of the junctions
was in general maintained (data not shown).
Together these experiments indicate that epithelial integrity is
maintained in CAR-deficient animals.
Discussion
In this study we have created and analyzed a conditional Car
knockout mouse, in which we have used the Cre-loxP system to
disrupt the Car gene in adult mice. Previously reported Car
Figure 6. The total number of thymocytes is increased in cKO mice. Total number of thymocytes in tamoxifen-treated F/F;Cre (cKO, n = 6)
and littermate F/F controls (Ctrl, n = 6). The number of cells in cKO mice is shown as percent of cells in controls. Data are presented as mean 6 SEM.
P,0.05. (B) Flow cytometric analysis of thymocyte populations (thymus) and T cell subsets (spleen) in cKO and control (Ctrl) mice. Single cells are
displayed on a dot plot of CD4 versus CD8. CD8: (CD8+ single positive); CD4: (CD4+ single positive); DP: (CD4+/CD8+ double positive); DN: (CD42/
CD82 double negative). Experiments were performed three times.
doi:10.1371/journal.pone.0020203.g006
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knockout models have either targeted the Car gene in the germline
causing an embryonic lethal phenotype, or used a cardiac-specific
disruption of the CAR gene causing an embryonic lethal
phenotype if induced during embryo development or a severe
atrioventricular (AV) block if induced in adult mice [8,9,10,11,12].
This is the first study in which Car is ablated in all tissues in the
adult mouse, enabling a more integrated analysis of the
physiological role of the CAR protein in vivo.
Our results demonstrate that the Car gene can be irreversibly
inactivated in a broad range of tissues in adult F/F;Cre mice in the
presence of tamoxifen. One important exception is the liver, which
maintained CAR expression also after repeated periods of
tamoxifen administrations. The lack of tamoxifen-mediated Cre
recombination in the liver has been described previously, but the
reasons remain unknown [33].
A panel of experiments were performed to analyze the effect of
CAR depletion on the major organ systems in adult mice. Several
interesting phenotypes were observed, all irreversible with no
difference between male and females (data not shown). No changes
were observed in F/+;Cre heterozygotes (data not shown).
CAR-depleted mice demonstrated a striking atrophy of the
exocrine part of the pancreas. Considering the known functional
overcapacity of exocrine pancreas, it seems likely that the small
areas of remaining unaffected parenchyma found in cKO mice
was enough to maintain growth and longevity in cKO mice. In the
cKO animals, numerous duct-like tubular complexes were
Figure 7. The integrity of the epithelial lining in intestines of cKO mice is maintained. (A) Tamoxifen-treated F/F;Cre (cKO, n= 11) and
littermate F/F controls (Ctrl, n = 11) were given a fluorescent tracer by gavage and the permeability of the intestinal epithelium was analyzed by
measuring the presence of fluorescence tracer in serum 4 hrs later. No statistically significant difference was found between the two groups. Data is
shown as mean 6 SD. P= 0.274. (B) Histology of small intestine harvested two weeks after the last tamoxifen administration from F/F control (Ctrl)
and F/F;Cre (cKO) animals. No difference between cKO and control animals was found. Scale bar = 100 mm (C) Indirect immunofluorescence of large
intestine from F/F;Cre (cKO) and littermate F/F control (Ctrl) mice two weeks after the last tamoxifen administration. Primary antibodies were directed
against CAR (green) and occludin (red). DAPI was used to visualize nuclei (blue). Magnification was 406. (i) and (ii) are enlargements of the boxed
areas in the merged ctrl and cKO images, respectively. The experiment was performed three times.
doi:10.1371/journal.pone.0020203.g007
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observed. No tubular complexes were found in the remnants of
normal exocrine pancreas in the cKO animals, indicating that
acinar cell depletion is a prerequisite for the development of these
complexes. The formation of tubular complexes//acinar meta-
plasia in the pancreas is thought to be a response to pancreatic
injury and has been observed in several conditions including
pancreatitis, chemically induced carcinogenesis, duct ligation,
pancreatectomy, chronic hyperglycemia and animal models of
diabetes [38,39,40,41,42,43,44,45]. Although a transient infiltra-
tion of inflammatory cells was seen in the pancreas early after
tamoxifen administration, this condition was not sustained
indicating that the formation of tubular complexes in the cKO
mice was not the result of chronic pancreatitis. In addition, no
obstruction in ducts from the pancreas, liver or gall bladder and no
malignant growth were observed in the cKO mice. Formation of
tubular complexes in the pancreas has been suggested to originate
from either proliferating pre-existing pluripotent cells, collapsed
pre-existing ducts or from an acinar-to-ductal transdifferentiation
process [46]. It was recently shown that exocrine cells might also
transdifferentiate into ß cells via a tubular complex intermediate
[47,48]. Thus, tubular complexes appear to be unique structures
harboring progenitor cells that, under appropriate conditions,
might reconstitute islet ß-cells as well as exocrine pancreas as part
of a tissue regenerative process.
It was recently demonstrated that mice with a pancreas-specific
loss of Car from embryonic day 8 appeared normal [49]. We have
created a similar mouse strain in which Cre expression is driven by
the same pancreas-specific promoter [50]. In agreement with the
results from Kallewaard et al, we could not demonstrate any
abnormalities in the pancreas of these knockout mice in either the
absence or presence of tamoxifen (data not shown). These results
indicate that compensatory mechanisms must be operating in the
pancreas if Car is deleted during embryo development. Alterna-
tively, the pancreas-specific promoter may not express Cre in gall
duct or other cells that might be important for CAR functions.
In addition to the atrophy of pancreas, cKO animals also
displayed dilated intestines. The diameter along the whole
intestinal system was significantly increased, while the length of
the intestinal tract was normal. No signs of diarrhea, constipation,
polyps, neoplasias or inflammation were observed. Histological
analysis revealed a normal sized epithelium with no increase in cell
proliferation in the crypts. The integrity of the intestinal
epithelium was maintained in cKO animals. Together these
results indicate that the enlarged intestines are not due to the lack
of CAR in epithelial cells in the intestines, but instead might result
from other alterations e.g. malfunctioning exocrine pancreas.
Reduced secretion of pancreatic enzymes may result in an increase
in remaining undigested material in the intestines and an increase
in water content due to compensatory osmotic reactions. It is also
possible that an altered motility of the gut affects the propulsion of
the intestinal content. One mechanism could be an altered
electrical activity of the smooth muscle or altered neuro/hormonal
regulation of the gut motility. In view of the effects of CAR on
impulse propagation in the heart, it could be possible that gap-
junctional function in the gut is altered.
Car cKO mice showed a small, but statistical significant,
increase in the total number of thymocytes in the thymus. No
difference between cKO and controls animals in the rate of
proliferation of any of the four main populations of thymocytes or
in the sensitivity to glucocorticoid-induced apoptosis was found.
The significance of this finding is at present unclear.
In agreement with previous reports, we show that disruption of
the Car gene results in complete (or 3rd degree) AV block with a full
dissociation between atrial and ventricular excitation. The
pacemaker responsible for the ventricular excitation is not
identified. However, the ventricular rate and the shape of the
QRS complexes are similar to those of the controls, which suggest
that the pacemaker is located comparatively high in the
conduction system. The faster ventricular frequency in cKO
compared to control mice is in contrast to the bradycardia
observed in mice following radiofrequency ablation of the AV
node in experimental models of AV block, and in human AV
block [51]. Our analysis included animals of different ages that
had received different tamoxifen protocols. In all of these
subgroups AV block was consistently observed in cKO mice,
showing that conditional Car ablation results in a persistent loss of
conduction in the AV node. No other signs of conduction failure
(e.g. broadening of the qrs complexes) could be demonstrated.
Histologically the heart appeared normal with no signs of
increased proliferation, apoptosis, thoracic hemorrhage or late
onset myocardial fibrosis. Transmission electron microscopy
however revealed morphological changes with less well-defined
contacts between myocytes in the cKOs. These results are well in
line with the suggested role of CAR in organization of cell-cell
contacts and the crosstalk between CAR and connexin proteins in
the heart [12,13].
The mechanisms behind the novel phenotypes reported in this
study in not known. CAR is expressed in the intercalated discs of
the heart, in tight junctions of the intestinal epithelium and the
epithelium of pancreatic ducts, and in the epithelial reticular cells
of the thymus [4,11]. The localization of CAR to cell-cell contacts
indicates that CAR might be important for the structural integrity
of cells and tissues. Loss of CAR in the heart results in structural
defects between myocytes and dysfunctional propagation of
electrical signals. Cross talk between tight junctions and gap
junctions is affected and mislocalization of connexins, ß-catenin
and ZO-1 is observed [11,12]. Our analyses of the intestinal
epithelium did however not reveal any structural defects, leaking
epithelium or mislocalization of Occludin or ZO-1 in the cKO
mice. In addition, although leakage of the ductal epithelium in
the pancreas was not directly analyzed, this scenario is less likely
since a leakage of potent digestive enzymes into the surrounding
tissue would probably cause pancreatitis, which was not observed
in the cKO mice. Thus CAR might have function(s) beyond
structural integrity. To reveal these function(s) requires further
experimentation.
The multi-organ manifestation of the phenotype in Car cKO
mice might reflect a syndrome associated with lack of function in
the CAR protein. It is clear that one of the main functions of the
protein is related to tight junctional activity as manifested by the
clear cardiac phenotype. Our novel finding that the pancreas is
dramatically affected and that the intestine is dilated suggests that
a human equivalent phenotype would exhibit clinical symptoms
from both heart and the gastro-intestinal system. Obviously, global
deletion of CAR affects embryonic development and a global
ablation might not be relevant for conditions in man. Since human
pathological genotypes often are heterozygous, milder symptoms
in man might be expected.
In conclusion, this paper confirms the previously reported
function for CAR in conduction of electric signals in the heart. We
also report novel functions of CAR in maintaining the exocrine
pancreas and possible also intestines and thymus of adult mice. All
phenotypes show a 100% penetrance and appear to be
irreversible. Future studies are needed to address the mechanism(s)
behind these phenotypes and link the mouse phenotypes to a
clinical genetic syndrome or other, possibly virus related, changes
in CAR in man.
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